ES2053429T3 - El uso de buspirona para la preparacion de composiciones farmaceuticas para aliviar la ansiedad fobica. - Google Patents

El uso de buspirona para la preparacion de composiciones farmaceuticas para aliviar la ansiedad fobica.

Info

Publication number
ES2053429T3
ES2053429T3 ES86114795T ES86114795T ES2053429T3 ES 2053429 T3 ES2053429 T3 ES 2053429T3 ES 86114795 T ES86114795 T ES 86114795T ES 86114795 T ES86114795 T ES 86114795T ES 2053429 T3 ES2053429 T3 ES 2053429T3
Authority
ES
Spain
Prior art keywords
buspirone
anxiety
phobical
relieve
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES86114795T
Other languages
English (en)
Inventor
Neil M Kurtz
Roger E Newton
Davis L Temple Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2053429T3 publication Critical patent/ES2053429T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA BUSPIRINA Y SUS SALES ACEPTABLES FARMACEUTICAMENTE SON UTILIZADAS EN LA ATENUACION DE TRANSTORNOS DE PANICO LOS CUALES PUEDEN TOMAR LA FORMA DE SINDROMES CLINICOS QUE INCLUYEN, POR EJEMPLO, ATAQUES DE PANICO, AGORAFOBIA Y ANSIEDAD FOBICA.
ES86114795T 1985-10-25 1986-10-24 El uso de buspirona para la preparacion de composiciones farmaceuticas para aliviar la ansiedad fobica. Expired - Lifetime ES2053429T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/791,182 US4634703A (en) 1985-10-25 1985-10-25 Method for alleviation of panic disorders

Publications (1)

Publication Number Publication Date
ES2053429T3 true ES2053429T3 (es) 1994-08-01

Family

ID=25152914

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86114795T Expired - Lifetime ES2053429T3 (es) 1985-10-25 1986-10-24 El uso de buspirona para la preparacion de composiciones farmaceuticas para aliviar la ansiedad fobica.

Country Status (11)

Country Link
US (1) US4634703A (es)
EP (1) EP0220696B1 (es)
JP (1) JPH0667841B2 (es)
AT (1) ATE86858T1 (es)
AU (1) AU592121B2 (es)
CY (1) CY1786A (es)
DE (1) DE3688038T2 (es)
ES (1) ES2053429T3 (es)
GR (1) GR3007393T3 (es)
HK (1) HK87094A (es)
ZA (1) ZA867670B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777173A (en) * 1987-03-25 1988-10-11 Bristol-Myers Company Method for treatment of alcohol abuse
US4782060A (en) * 1987-07-29 1988-11-01 Bristol-Myers Company Gepirone for alleviation of panic disorders
SE8704097D0 (sv) * 1987-10-22 1987-10-22 Astra Ab Oral formulation of buspirone and salts thereof
DE3736974A1 (de) * 1987-10-31 1989-05-11 Troponwerke Gmbh & Co Kg Verwendung von 2-pyrimidinyl-1-piperazin-derivaten
US5468749A (en) * 1988-08-30 1995-11-21 Gawin; Frank H. Method for treatment of substance addiction
US6432956B1 (en) 1990-02-12 2002-08-13 William C. Dement Method for treatment of sleep apneas
US5166202A (en) * 1990-09-19 1992-11-24 Trustees Of The University Of Pennsylvania Method for the treatment of panic disorder
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
JPH04327532A (ja) * 1991-01-31 1992-11-17 Bristol Myers Squibb Co 活動過剰を伴う注意力欠乏疾患の治療に使用する医薬製剤
US5431922A (en) * 1991-03-05 1995-07-11 Bristol-Myers Squibb Company Method for administration of buspirone
US5457100A (en) * 1991-12-02 1995-10-10 Daniel; David G. Method for treatment of recurrent paroxysmal neuropsychiatric
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
EP0651816A4 (en) * 1992-07-15 1995-10-25 Univ South Florida LEVELS OF CCK PEPTIDES IN BLOOD IN RELATION TO THE TREATMENT OF PANIC EARTHS.
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
CA2165802A1 (en) * 1993-09-29 1995-04-06 Eun Soo Lee Monoglyceride/lactate ester permeation enhancer for oxybutynin
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
US8134029B2 (en) 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
US7588732B2 (en) * 2004-03-30 2009-09-15 Genesis Biosystems, Inc. Autologus tissue harvesting and irrigation device
JP2009500425A (ja) 2005-07-06 2009-01-08 セプラコア インコーポレーテッド エスゾピクロン及びトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−ｎ−メチル−１−ナフタレンアミン又はトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
EP2816024B8 (en) 2006-03-31 2018-04-04 Sunovion Pharmaceuticals Inc. Chiral amines
WO2008036846A2 (en) * 2006-09-22 2008-03-27 Braincells, Inc. Combination comprising an hmg-coa reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis
US20120077818A1 (en) * 2009-05-13 2012-03-29 Sunovion Pharmaceuticals Inc. Compositions comprising transnorsertraline and serotonin receptor 1a agonists/antagonists and uses thereof
RU2660583C1 (ru) * 2017-08-15 2018-07-06 Общество С Ограниченной Ответственностью "Валента - Интеллект" Применение буспирона для лечения функционального головокружения

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987052A (en) * 1969-03-17 1976-10-19 The Upjohn Company 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4508726A (en) * 1982-09-16 1985-04-02 The Upjohn Company Treatment of panic disorders with alprazolam
US4438119A (en) * 1982-12-23 1984-03-20 Mead Johnson & Company Method for alleviation of extrapyramidal motor disorders

Also Published As

Publication number Publication date
ZA867670B (en) 1987-06-24
CY1786A (en) 1995-10-20
EP0220696A3 (en) 1989-10-04
JPH0667841B2 (ja) 1994-08-31
EP0220696B1 (en) 1993-03-17
DE3688038T2 (de) 1993-07-01
JPS62111924A (ja) 1987-05-22
HK87094A (en) 1994-09-02
EP0220696A2 (en) 1987-05-06
US4634703A (en) 1987-01-06
AU592121B2 (en) 1990-01-04
AU6424586A (en) 1987-04-30
DE3688038D1 (de) 1993-04-22
GR3007393T3 (es) 1993-07-30
ATE86858T1 (de) 1993-04-15

Similar Documents

Publication Publication Date Title
ES2053429T3 (es) El uso de buspirona para la preparacion de composiciones farmaceuticas para aliviar la ansiedad fobica.
IT1201087B (it) Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
ES2061799T3 (es) Nuevo preparado medicamentoso y procedimiento para su preparacion.
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
SE8804629D0 (sv) New therapeutically active compounds
IT8719763A0 (it) Analoghi retro-inversi della timopentina e dei suoi frammenti, il metodo per la loro sintesi ed il loro impiego per la preparazionedi composizioni farmaceutiche.
ES2059312T3 (es) Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion.
IT8619284A0 (it) Composizione per la preparazione estemporanea di formulazioni per applicazioni topiche per uso farmaceutico e cosmetico.
IT1241079B (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
IT9020020A0 (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
IT1200944B (it) Derivati xantinici,procedimento per la loro preparazione,composizione farmaceutiche che il contengono e loro impiego terapeutico
ITRM950273A0 (it) Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni farmaceutiche.
ES2036174T3 (es) Un procedimiento para la preparacion de una combinacion broncodilatadora de prazosin-pirbuterol.
DK144885A (da) Substituerede 4-hydroxybenzopyraner eller farmaceutisk acceptable additionssalte deraf, deres fremstilling og anvendelse som laegemidler
IT8423517A0 (it) Composizione farmaceutica per combattere infezioni virali, eprocedimento di uso per le infezioni virali.
ES2059442T3 (es) Uso de gepirona para la preparacion de composiciones farmaceuticas para mitigar alteraciones de panico.
NO871190D0 (no) Fremgangsmaate for fremstilling av farmakologisk aktive substituerte anilider.
ITMI910846A0 (it) Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1277926B1 (it) Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire
IT8648565A0 (it) Derivati di acido tiofenacetico,procedimento per la loro preparazione, composizioni farmaceutiche che licontengono e loro impiego come medicamenti
IT8747852A0 (it) Benzammidi sostituite, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
IT8823099A0 (it) Nuovi analoghi retro-inversi della timopentina, il metodo per la loro sintesi ed il loro impiego per la preparazione di composizioni farmaceutiche
SE8700829L (sv) Farmaceutisk komposition
HN1997000048A (es) 1,3 - oxatiolanos sustituidos con propiedades antiviricas.
IT1150451B (it) Composizione farmaceutica ad attivita'analgesica,antiretica e antiinfiammatoria e procedimento per la preparazione del principio attivo

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 220696

Country of ref document: ES